Skye Bioscience, Inc Common Stock (SKYE) has a market capitalization of $168.3M, based on 52.58M shares at a price of $3.20 (up 2.2% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
February 2025 | $3.11 | 2,239,829 | 52,579,884 | $163,523,439.24 |
January 2025 | $3.21 | 3,410,155 | 52,579,884 | $168,781,427.64 |
December 2024 | $2.83 | 4,578,004 | 38,819,400 | $109,858,902.00 |
November 2024 | $4.49 | 3,170,624 | 38,819,400 | $174,299,106.00 |
October 2024 | $5.24 | 6,272,800 | 38,819,400 | $203,413,656.00 |
September 2024 | $3.91 | 10,752,522 | 38,819,400 | $151,783,854.00 |
August 2024 | $6.19 | 4,269,063 | 38,819,400 | $240,292,086.00 |
July 2024 | $5.17 | 4,180,365 | 38,819,400 | $200,696,298.00 |
June 2024 | $8.01 | 8,302,503 | 38,669,300 | $309,741,093.00 |
May 2024 | $11.61 | 1,127,777 | 38,669,300 | $448,950,573.00 |
April 2024 | $12.93 | 1,335,945 | 38,669,300 | $499,994,049.00 |
March 2024 | $15.64 | 833,323 | 27,999,900 | $437,918,436.00 |
February 2024 | $14.56 | 652,557 | 27,999,900 | $407,678,544.00 |
January 2024 | $4.00 | 95,178 | 27,999,900 | $111,999,600.00 |
December 2023 | $2.72 | 321,943 | 12,349,200 | $33,589,824.00 |
November 2023 | $1.61 | 89,913 | 12,349,200 | $19,882,212.00 |
October 2023 | $1.75 | 99,899 | 12,349,200 | $21,611,100.00 |
September 2023 | $4.09 | 181,253 | 971,549,600 | $3,973,637,864.00 |
August 2023 | $4.50 | 217,171 | 971,549,600 | $4,371,973,200.00 |
July 2023 | $5.75 | 77,471 | 971,549,600 | $5,586,410,200.00 |
June 2023 | $5.33 | 80,610 | 971,549,600 | $5,173,501,620.00 |
May 2023 | $3.68 | 106,411 | 971,549,600 | $3,570,444,780.00 |
April 2023 | $3.33 | 93,403 | 971,549,600 | $3,230,402,420.00 |
March 2023 | $4.35 | 117,695 | 971,549,600 | $4,226,240,760.00 |
February 2023 | $7.70 | 198,529 | 971,549,600 | $7,480,931,920.00 |
